Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003

Thorax

Volumn 62, Issue 8, 2007, Pages 661-666

  Marras, Theodore K ^a,b   Chedore, Pamela ^c   Ying, Alicia M ^b   Jamieson, Frances ^c  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; HUMAN; LABORATORY TEST; LUNG INFECTION; MEDICAL RECORD; MEDICAL SOCIETY; MICROBIOLOGY; MYCOBACTERIUM; MYCOBACTERIUM GORDONAE; PREVALENCE; PRIORITY JOURNAL;

COHORT STUDIES; HUMANS; LUNG DISEASES; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS; ONTARIO; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 34347350074     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.070797     Document Type: Article

References (33)

1. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:S1-19.
2. British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 2000;55:210-8.
3. Larsson LO, Bentzon MW, Lind A, et al. Sensitivity to sensitins and tuberculin in Swedish children. Part 5: A study of school children in an inland rural area. Tuberc Lung Dis 1993;74:371-6.
4. Robakiewicz M, Grzybowski S. Epidemiological aspects of non-tuberculous mycobacterial disease and of tuberculosis in British Columbia. Am Rev Respir Dis 1974;109:613-20.
5. DuMoulin GC, Sherman IH, Hoaglin DC, et al. Mycobacterium avium complex, an emerging pathogen in Massachusetts. J Clin Microbiol 1985;22:9-12.
6. Isaac-Renron JL, Allen EA, Chao CW, et al. Isolation and geographic distribution of Mycobacterium other than M tuberculosis in British Columbia, 1972-81. CMAJ 1985;133:573-6.
7. Debrunner M, Salfinger M, Brandli O, et al. Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis 1992;15:330-45.
8. Kubin M, Svandova E, Medek B, et al. Mycobacterium kansasii infection in an endemic area of Czechoslovakia. Tubercle 1980;61:207-12.
9. Sakatani M. Nontuberculous mycobacteriosis; the present status of epidemiology and clinical studies (in Japanese). Kekkaku 1999;74:377-84.
10. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002;23:553-67.
11. Martin Casabona N, Bahrmand AR, Bennedsen J, et al. Non-tuberculous mycobcteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 2004;8:1186-93.
12. Hanna BA, Ebrahimzadeh A, Elliott LB, et al. Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol 1999;37:748-52.
13. Butler WR, Guthertz LS. Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin Microbiol Rev 2001;14:704-26.
14. Arnow PM, Bakir M, Thompson K, et al. Endemic contamination of clinical specimens by Mycobacterium gordonae. Clin Infect Dis 2000;31:472-6.
15. Vik J. Epidemiology of tuberculosis in Ontario, 1999-2001. Public Health and Epidemiology Report Ontario 2003;14:105-15.
16. Ministry of Health and Long-Term Care. Summary of reportable diseases in Ontario - 4th quarter 2003. Public Health and Epidemiology Report Ontario 2004;15:73-5.
17. Haverkort F. National atypical mycobacteria survey, 2000. Commun Dis Intell 2003;27:180-9.
18. Donnabella V, Salazar-Schicchi J, Bonk S, et al. Increasing incidence of Mycobacterium xenopi at Bellevue Hospital: an emerging pathogen or a product of improved laboratory methods? Chest 2000;118:1365-70.
19. Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989;321:863-8.
20. Fogan L. PPD antigens and the diagnosis of mycobacterial diseases. Arch Intern Med 1969;124:49-54.
21. Ahn CH, Lowell JR, Onstad GD, et al. A demographic study of disease due to Mycobacterium kansasii or M intracellulare-avium in Texas. Chest 1979;75:120-5.
22. Trnka L, Dankova D, Svandova E. Six years' experience with the discontinuation of BCG vaccination: 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellular complex. Tuberc Lung Dis 1994;75:348-52.
23. Romanus V, Hallander HO, Wahlen P, et al. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG vaccination coverage. Tuberc Lung Dis 1995;76:300-10.
24. Ohkusus K, Bermudez LE, Nash KA, et al. Differential virulence of Mycobacterium avium strains isolated from HIV-infected patients with disseminated M avium complex disease. J Infect Dis 2004;190:1347-54.
25. Meyer M, von Grunberg PW, Knoop T, et al. The macrophage-induced gene mig as a marker for clinical pathogenicity and in vitro virulence of Mycobacterium avium complex strains. Infect Immun 1998;66:4549-52.
26. Gangadharam PR, Perumal VK, Jairam BT, et al. Virulence of Mycobacterium avium complex strains from acquired immune deficiency syndrome patients: relationship with characteristics of the parasite and host. Microb Pathog 1989;7:263-78.
27. O'Brien DP, Currie BJ, Krause VL. Nontuberculous mycobacterial disease in Northern Australia: a case series and review of the literature. Clin Infect Dis 2000;31:958-68.
28. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 1987;135:1007-14.
29. Good RC. Isolation of non-tuberculous mycobacteria in the United States, 1979. J Infect Dis 1980;142:779-83.
30. Good RC, Snider DE Jr. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 1982;146:829-33.
31. Contreras MA, Cheung OT, Sanders DE, et al. Pulmonary infection with nontuberculous mycobacteria. Am Rev Respir Dis 1988;137:149-52.
32. Simor AE, Salit IE, Vellend H. The role of Mycobacterium xenopi in human disease. Am Rev Respir Dis 1984;129:435-8.
33. Jiva TM, Jacoby HM, Weymouth LA, et al. Mycobacterium xenopi: innocent bystander or emerging pathogen? Clin Infect Dis 1997;24:226-32.